Invest Detroit的动态

TechTown Detroit and Venture 313 client CircNova, Inc’s founder, Crystal Brown, made news last week when she announced her $3.3 million pre-seed round in a TechCrunch exclusive article. The piece highlighted her journey, her vision, and how her startup is using AI to revolutionize drug discovery. ?? Her journey began with the Conquer Accelerator program at Michigan State University, followed by securing a $15,000 grant from Venture 313 to fund her patent application. As she proved CircNova’s concept, Brown built a team of industry leaders and advisors ranging from Michigan to Massachusetts to bring her disruptive vision for the future of RNA therapeutics to life.?? The round was led by South Loop Ventures and included additional investments from Dug Song, Invest Detroit, Union Heritage, Michigan Rise, Ann Arbor SPARK, Kalamazoo Forward Ventures, and several others. CircNova’s AI-driven biotech approach aims to unlock a new era of drug development, using AI to design circular RNA structures that were previously very difficult to create, leveraging their proprietary NovaEngine?. ?? Now, she’s focused on building CircNova’s base in Detroit as the company continues developing technologies to identify therapeutic solutions.